Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.16% to 1,739.95 Indian rupees Monday, on what proved to be an all-around grim trading session for the stock market, with the BSE SENSEX ...

The pharmaceutical business Sun Pharma held the meeting on January 31, 2025. The company announced the record date and ...

Tariffs on major trading partners could initially hurt stocks. Read why I remain bullish and expect strong earnings from S&P ...

A recap of the most heavily shorted stocks on the ASX and those experiencing significant changes to short interest over the ...

Sun Pharma's Q3FY25 net profit rose 15% YoY to ₹2,903 crore, driven by strong domestic and global specialty sales. Revenue ...

Results: The company has also declared an interim dividend of Rs 10.5 per share for the financial year 2024-25.

Analysts see support at 23,200, and a break below this level could trigger a decline towards 23,000. On the other hand, a decisive move above 23,300 might push the index towards 23,500.

The Nifty50 index is expected to have established a short-term bottom near the 22,800 mark, with immediate support at 22,780.